Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
107.03
-6.81 (-5.98%)
May 12, 2026, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 10.11 billion as of May 12, 2026. Its market cap has increased by 2.63% in one year.
Market Cap
10.11B
Enterprise Value
9.06B
Revenue
427.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
107.03
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 10.11B, an increase of 129.36%. That is a compound annual growth rate of 13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 9.51B | -33.93% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 11.13B |
| Chengdu Easton Biopharmaceuticals | 10.99B |
| HitGen | 10.78B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.15B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.04B |
| Jiangxi Fushine Pharmaceutical | 9.90B |
| Liaoning Chengda Biotechnology | 9.78B |
| Youcare Pharmaceutical Group | 9.56B |